ATE212040T1 - Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen - Google Patents

Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen

Info

Publication number
ATE212040T1
ATE212040T1 AT98902905T AT98902905T ATE212040T1 AT E212040 T1 ATE212040 T1 AT E212040T1 AT 98902905 T AT98902905 T AT 98902905T AT 98902905 T AT98902905 T AT 98902905T AT E212040 T1 ATE212040 T1 AT E212040T1
Authority
AT
Austria
Prior art keywords
cross
linked
high amylose
amylose starch
reaction medium
Prior art date
Application number
AT98902905T
Other languages
English (en)
Inventor
Yves Dumoulin
Francois Carriere
Andre Ingenito
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Application granted granted Critical
Publication of ATE212040T1 publication Critical patent/ATE212040T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B33/00—Preparation of derivatives of amylose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
AT98902905T 1997-02-14 1998-02-10 Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen ATE212040T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,518 US5807575A (en) 1997-02-14 1997-02-14 Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
PCT/CA1998/000106 WO1998035992A1 (en) 1997-02-14 1998-02-10 Manufacture of cross-linked amylose useful as an excipient for control release of active compounds

Publications (1)

Publication Number Publication Date
ATE212040T1 true ATE212040T1 (de) 2002-02-15

Family

ID=25178603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98902905T ATE212040T1 (de) 1997-02-14 1998-02-10 Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen

Country Status (12)

Country Link
US (1) US5807575A (de)
EP (1) EP0960131B1 (de)
AT (1) ATE212040T1 (de)
AU (1) AU726272B2 (de)
CA (1) CA2280534C (de)
DE (1) DE69803159T2 (de)
DK (1) DK0960131T3 (de)
ES (1) ES2171008T3 (de)
IL (1) IL131369A (de)
NZ (1) NZ337171A (de)
PT (1) PT960131E (de)
WO (1) WO1998035992A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6624200B2 (en) 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
EP1347748A2 (de) 2000-12-05 2003-10-01 MacGregor, Alexander Hydrostatisches abgabesystem für die kontrollierte abgabe eines mittels
CA2423712A1 (en) 2003-03-26 2004-09-26 Nicolas Nourry Crosslinked amylopectin by reactive extrusion and its use as an absorbent or superabsorbent material
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
AU2003294244A1 (en) * 2002-11-07 2004-06-03 Advanced Bionutrition Corp. Nutraceuticals and method of feeding aquatic animals
US6846497B2 (en) * 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20080318311A1 (en) 2004-11-02 2008-12-25 Gangagen Life Sciences Inc. Encapsulated Bacteriophage Formulation
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
JP5269595B2 (ja) 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
WO2007105719A1 (ja) * 2006-03-14 2007-09-20 National University Corporation NARA Institute of Science and Technology 新規なヘパリン代替材料およびその製造方法
ES2541809T3 (es) * 2007-10-16 2015-07-24 Paladin Labs Inc. Composición bicapa para la liberación sostenida de acetaminofeno y tramadol
US8563066B2 (en) * 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
KR101561571B1 (ko) 2007-12-28 2015-10-19 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 글리코겐과 알긴산염의 회합을 기초로 한 서방형 제제
CN102118970A (zh) 2008-07-16 2011-07-06 吉瑞工厂 包含多巴胺受体配体的药物制剂
WO2010028489A1 (en) * 2008-09-15 2010-03-18 Labopharm Inc. Starch-based microparticles for the release of agents disposed therein
EA026651B1 (ru) 2009-01-23 2017-05-31 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Фармацевтический или пищевой состав с контролируемым высвобождением и способ его получения
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
GB2567493B (en) 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4667590A (en) * 1984-12-10 1987-05-26 Mars, Inc. Closed food processing system and liquid adjustment apparatus for use therein
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
KR100304997B1 (ko) * 1992-07-24 2002-04-24 드니랑글로아 효소에의해제어되는약물방출을위한가교결합된폴리하이드록실물질을포함하는정제

Also Published As

Publication number Publication date
EP0960131A1 (de) 1999-12-01
IL131369A0 (en) 2001-01-28
US5807575A (en) 1998-09-15
NZ337171A (en) 2000-09-29
AU726272B2 (en) 2000-11-02
DE69803159D1 (de) 2002-02-21
DK0960131T3 (da) 2002-05-06
CA2280534C (en) 2003-08-19
IL131369A (en) 2002-12-01
WO1998035992A1 (en) 1998-08-20
EP0960131B1 (de) 2002-01-16
ES2171008T3 (es) 2002-08-16
DE69803159T2 (de) 2002-08-29
CA2280534A1 (en) 1998-08-20
AU5978598A (en) 1998-09-08
PT960131E (pt) 2002-06-28

Similar Documents

Publication Publication Date Title
ATE212040T1 (de) Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen
WO2002002084A8 (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
ES2041885T3 (es) Un procedimiento para la fabricacion de un producto gelificado.
KR900701806A (ko) 올리고 -및/또는 폴리사카리드로 부터 얻은 알킬글루코시드 화합물의 제조방법
JP3791552B2 (ja) 錠剤用賦形剤としてのデンプン製品及びその調製方法及び錠剤の製造方法
PL358378A1 (en) Process for cooking/drying high-amylose starches
ATE65940T1 (de) Kontinuierliches verfahren zur herstellung von natriumperborat-granulaten.
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
Kurakake et al. Effects on maize starch properties of heat-treatment with water–ethanol mixtures
BRPI0410977A (pt) processo para a fabricação de granulado de enzima e granulados de enzima obtidos
WO1999009066B1 (en) Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
DE60022443D1 (de) Granulierung von Stärke
ATE154754T1 (de) Verfahren zur herstellung von pvp-h202-produkten
US3070595A (en) Process for producing polysulfuric acid esters of polysaccharides
US20020132309A1 (en) Enzamatically modified hydrophobic starch
NO976096L (no) FremgangsmÕte for fremstilling av por°se granuler og anlegg for utf°relse av fremgangsmÕten
DE69306818D1 (de) Verfahren zur Herstellung von destrukturierter Stärke
BR0211841A (pt) Secagem de artigos cerâmicos durante manufatura
BR0012939A (pt) Tablete de uma composição particulada compactada, e, processos para produzir grânulos, e para produzir um tablete
DE50209196D1 (de) Verfahren zur herstellung von bleichaktivatorgranulaten
KR950011475A (ko) 사이클로덱스트린의 제조방법
TH62467B (th) กรรมวิธีสำหรับการผลิตไอโซมอลโทส และการใช้ของมัน
JPH02193969A (ja) テトラヒドロイソキノリン―３―カルボン酸の製造方法
TH20000A (th) แป้งและผงแป้งที่ใด้ยับยั้งแล้งด้วยความร้อน และขบวนการสำหรับการผลิต
TH25111B (th) แป้งและผงแป้งที่ใด้ยับยั้งแล้งด้วยความร้อน และขบวนการสำหรับการผลิต

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee